CMS reached its goals for value-based payments in part because of providers’ enthusiasm for new programs, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
CMS reached its 2016 goals for transition to value-based payments early in part because of providers’ enthusiasm for new programs, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS.
Transcript (slightly modified)
What do you attribute to CMS successfully reaching its 2016 goals for moving to value-based payments 9 months before the deadline?
I think we were able to do this because there have been so many collaborators and partners out there who have been really excited about joining in with the alternative payment models that the Innovation Center had out there. So in the latest few years, we’ve had not only of course the Medicare Shared Savings Program, the three different tracks of that shared savings program, the Pioneer Program which is also an ACO program, as well as our bundled payment programs. And last year we launched the Comprehensive Joint Replacement Model, of course that didn’t go into effect until April of this year so it didn’t have that impact yet.
But I think because we launched a number of models but with tremendous enthusiasm from in particular the provider community, but also from other payers who really wanted to join in with us in aligning the incentives for clinicians in practice, we were really able to leverage that enthusiasm to be successful with the 30 percent goal, as you stated, much earlier than we anticipated.
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most
March 13th 2025On December 10, 2024, cardiologists, researchers, and value-based care experts gathered in Dallas, Texas, to discuss best practices for implementing advances in cardiology care with a value-based mindset, spanning the care continuum from prevention to treatment.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More